Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly

See also
Status	Clinical Trial	Phase
Completed	`NCT00105040` - A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures	Phase 2
Completed	`NCT00160615` - Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method	Phase 3
Completed	`NCT00152516` - Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures	Phase 3
Completed	`NCT00113165` - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures	Phase 3
Completed	`NCT00175890` - A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.	Phase 3
Withdrawn	`NCT01691872` - Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects	Phase 1
Completed	`NCT00160654` - Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy	Phase 4
Terminated	`NCT01545518` - IVIG Treatment for Refractory Immune-Related Adult Epilepsy	Phase 2
Completed	`NCT00141414` - To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.	Phase 2
Completed	`NCT01332539` - An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy	N/A
Completed	`NCT00355082` - Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy	Phase 3
Completed	`NCT00152451` - Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures	Phase 2
Withdrawn	`NCT02220972` - To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures	Phase 4
Completed	`NCT00160628` - Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy	Phase 3
Completed	`NCT00245713` - Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.	Phase 4
Terminated	`NCT01375374` - Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide	Phase 3
Completed	`NCT00152373` - Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS	Phase 3
Completed	`NCT00150709` - A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy	Phase 3
Completed	`NCT00643500` - Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy	Phase 4
Completed	`NCT00152503` - Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam	Phase 2

NCT number	NCT00280059
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	August 2006
Completion date	April 2010

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms